Plunkett Research Online: ICO Therapeutics, Inc.

ICO THERAPEUTICS, INC. (ICO:TSX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ICO Therapeutics, Inc. is a Canada-based search and development company which is focused on in-licensing drugs with clinical history redosing or reformulating for new or expanded indications......



ICO Therapeutics, Inc.
Ticker: ICO
Exchange: TSX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 604 602-9414
Fax: 604 602-9699
Address: 777 Hornby Street
6th Floor
Vancouver, BC V6Z 1S4 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Andrew RaeCEO/Director/President
Michael LiggettCFO/Secretary/Director
See More
ICO Therapeutics, Inc. is a Canada-based search and development company which is focused on in-licensing drugs with clinical history redosing or reformulating for new or expanded indications......See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: